We are a spin-off startup from the National University of Singapore.
We have developed a novel fluorogenic dye technology called Conjugated Oligoelectrolytes (COEs) for:
🔹 Extracellular Vesicles (EVs) Characterisation,
🔹 In Vivo Tumor Tracking,
🔹 Bacterial Gram-Typing,
🔹 Lipid Nanoparticles (LNPs) Research.
We are eager to explore other potential applications of our technology.
Our Acoerela dyes are the world's first full bilayer-spanning lipophilic dyes. They are water-soluble and exhibit high specificity, resulting in reduced background noise and false positives in comparison with traditional lipophilic dyes. Moreover, our dyes are intelligent and will fluoresce only when they bind to the target lipid membrane.
At Acoerela, we combines expertise in materials chemistry, biophysics, and life sciences. Our focus is on leveraging our patented dye technology to develop innovative optical probes for the global research community and 'lighting up' your research 🌈
Company Details
- Employees
- 6
- Founded
- -
- Address
- Singapore, Sg
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://acoerela.com
- Keywords
- optical probe, extracellular vesicles, exosomes, lipid nanoparticles, in vivo, cancer research.
- HQ
- Singapore
Acoerela Questions
Acoerela's website is http://acoerela.com
Acoerela's LinkedIn profile is https://sg.linkedin.com/company/acoerela
Acoerela has
6 employees.
View email and phone details for 6
employees at Acoerela.
Acoerela's industry is
Biotechnology Research
Acoerela's top competitors are
Beckman Coulter Life Sciences,
Bespark*bio,
Solv8 Technology,
Azenta Life Sciences(Apac),
Hyris,
Jotbody -Beyond Affinity-,
Green Elephant Biotech,
Dotbio,
Cortalix Bv,
Resmed.
Acoerela's categories are Biotechnology Research
Acoerela's founding year is 2022
